CompletedNot Applicable

Test Semiquantitative Prostate Specific Antigen (PSA)

France94 participantsStarted 2009-03

Plain-language summary

The aim of the study is to compare the diagnostic performances of a simple and rapid PSA assay on whole blood to the standard plasma PSA assay.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients followed for prostate cancer or symptomatic benign prostatic disease, and for who a PSA assay is indicated. * Patients must have given informed consent. Exclusion Criteria: * Patients followed for a disease other than prostatic.

What they're measuring

Determination of the sensitivity and specificity of the rapid PSA assay by comparing the results obtained from the test strip reading by three independent blinded observers with those from standard plasma PSA assay.

Timeframe: day of test

Trial details

NCT IDNCT00853710

SponsorInstitut Curie

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-07

View on ClinicalTrials.gov More Prostate Cancer trials